Response to Klar and Adams

J Natl Cancer Inst. 2022 Jan 11;114(1):167-168. doi: 10.1093/jnci/djab153.

Gwen M H E Dackus^{1

2}, Katarzyna Jóźwiak^{3

4}, Michael Hauptmann^{3

4}, Sabine C Linn^{1

2

5}

¹ Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, the Netherlands.
² Department of Pathology, University Medical Center Utrecht, Utrecht, the Netherlands.
³ Department of Epidemiology and Biostatistics, Netherlands Cancer Institute, Amsterdam, the Netherlands.
⁴ Institute of Biostatistics and Registry Research, Brandenburg Medical School Theodor Fontane, Neuruppin, Germany.
⁵ Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.

No abstract available

Publication types